Red White & Bloom (RWB) said it closed a strategic transaction with HEAL Botanicals Pharma, pursuant to which RWB now holds a controlling interest in HEAL Europe Holdings, a newly incorporated entity established by HEAL Botanicals Pharma.
HEH provides RWB with an integrated European medical cannabis platform comprising operations and investments in Germany, the United Kingdom and other European markets.
The European business includes the Grünhorn group of companies, which fulfilled approximately 290,000 medical cannabis prescriptions in the 12 months ended July 2026. Collectively, the businesses comprising the European platform dispensed or distributed more than 12 tons of medical cannabis in the same period.
“Over the past several months, we have strengthened and repositioned RWB through the strategic divesture of our Florida operations and expanded our Canadian platform through the recent acquisition of Ayurcann Inc.,” said Colby De Zen, President of RWB, in a statement. “With the foundation of the Company strengthened, we are now positioned to continue executing on our broader growth strategy. Closing this transaction marks an important milestone in that strategy and establishes a meaningful platform for RWB’s expansion into Europe. Germany has rapidly emerged as Europe’s largest medical cannabis market, while the United Kingdom represents another significant and growing opportunity. Importantly, we are entering these markets with established businesses, proven operating infrastructure and experienced teams already in place. We believe this gives RWB an exceptional foundation from which to scale, expand our presence and capitalize on the significant opportunities we see across the European market.”
RWB’s controlling interest in Leva HEAL Limited and Zerenia Clinics Limited, which operates a private medical cannabis clinic in the United Kingdom, provide it with exposure to the United Kingdom’s developing private medical cannabis and healthcare market.
